| 14th week of 2013 patent applcation highlights part 31 |
| Patent application number | Title | Published |
|---|
| 20130084190 | TITANIUM ALUMINIDE ARTICLES WITH IMPROVED SURFACE FINISH AND METHODS FOR THEIR MANUFACTURE - Titanium-containing articles having improved surface finishes and methods for improving surface finishes on titanium containing articles are provided. One method includes passing an abrasive medium across a surface of an titanium aluminide alloy-containing article, for example, a turbine blade, at high linear speed; deforming the surface of the titanium aluminide alloy-containing article with the abrasive medium and reducing a surface roughness of the surface of the titanium aluminide alloy-containing article and improving the surface finish of the surface. Surface finishes of 20 microinches Ra or less can be obtained. Though aspects of the invention can be used in fabricating high performance turbine blades, the methods disclosed can be applied to the treatment of any titanium-containing article for which it is difficult to obtain an improved surface finish. | 2013-04-04 |
| 20130084191 | TURBINE BLADE WITH IMPINGEMENT CAVITY COOLING INCLUDING PIN FINS - A turbine blade including an airfoil having a cavity defined between pressure and suction side walls, and first and second cooling circuits located within the cavity. The second cooling circuit includes a first upstream impingement cavity, a second upstream impingement cavity and a discharge impingement cavity. A plurality of pin fins are located within each of the impingement cavities, extending between the pressure and suction side walls to provide cooling to the pressure and suction side walls, and to restrict flow through the second cooling circuit and to direct an increased flow of cooling fluid into the first cooling circuit. | 2013-04-04 |
| 20130084192 | COOLING FAN CONTROL DEVICE AND CONTROL METHOD THEREOF - Disclosed herein are a cooling fan driving control device and a control method thereof non-linearly controlled to a duty ratio (%) of a PWM signal. The cooling fan driving control device includes a cooling fan control device including a temperature sensor, a microprocessor unit generating a PWM signal corresponding to a temperature measured by the temperature sensor, and a cooling fan driving unit driving the cooling fan according to a duty ratio of the PWM signal, comprising: a duty ratio detection unit receiving the PWM signal from the microprocessor unit to detect the duty ratio (%) of the PWM signal; and a duty ratio control device comparing the duty ratio (%) detected from the duty ratio detection unit with a predetermined threshold value, controlling the duty ratio (%) of the PWM signal according to the comparison results, and then, outputting the controlled PWM signal to the cooling fan driving unit. | 2013-04-04 |
| 20130084193 | MOTOR HOUSING THERMAL SENSING - A motor driven compressor apparatus includes a first stage compressor, a second stage compressor, an electric motor disposed between and coupled to the first stage compressor and the second stage compressor, thermal sensors disposed on the electric motor and configured to externally measure internal temperatures of the electric motor or internal bearings or components, and an external controller coupled to the electric motor and to the thermal sensors, and configured to at least one of slow down a speed of the electric motor and shut down the electric motor in response to at least one of an excess of a predetermined internal temperature and a rate of internal temperature change. | 2013-04-04 |
| 20130084194 | JET PUMP DATA TOOL SYSTEM - A jet pump, a jet pump data tool system, and method of use thereof. The jet pump includes a body having an intake, a first aperture, and a second aperture between the first aperture and the intake. A carrier is seated in the body and receivable in the first aperture. The carrier includes a venturi for drawing wellbore fluid from the intake into the venturi. A housing for a data tool extends from the carrier. The housing is in fluid communication with the intake for allowing wellbore fluid to be exposed to the data tool. The carrier is seatable in the body by flowing power fluid and the carrier into the first aperture. The carrier is retrievable from the body by flowing power fluid into the second aperture. | 2013-04-04 |
| 20130084195 | SWASH PLATE COMPRESSOR - A swash plate compressor | 2013-04-04 |
| 20130084196 | Aggregate, In Particular A Hybrid Engine, Electrical Power Generator Or Compressor - An aggregate, in particular a hybrid engine, electrical power generator or compressor, comprises a housing in which are arranged a piston motor part and an electric motor part, wherein the piston motor part has a first piston with a first end face and at least one second piston with a second end face, wherein the first piston and the at least one second piston perform reciprocating motions, wherein between the first end face and the second end face is provided a working chamber for a working medium, which chamber is periodically reduced and enlarged because of the reciprocating motions of the pistons, and wherein the electric motor part has an annular rotor which can rotate in the housing about a rotation axis that is fixed relative to the housing. The rotor surrounds the piston motor part. | 2013-04-04 |
| 20130084197 | FAN UNIT - A fan unit ( | 2013-04-04 |
| 20130084198 | PUMP WITH CENTRALIZED SPRING FORCES - A pump including a tappet biased into contact with a camshaft by a return spring is provided. The pump includes a torque transfer reduction interface mechanically interposed between the return spring and the tappet. The torque transfer reduction interface is configured to prevent spring wind-up generated by compressing and expanding the return spring from being transferred to the tappet to prevent the torque from causing the tappet to rotate relative to the camshaft about an axis extending perpendicular to the rotational axis of the camshaft. | 2013-04-04 |
| 20130084199 | PIEZOELECTRIC ACTUATOR, LIQUID TRANSPORT APPARATUS, AND METHOD FOR PRODUCING PIEZOELECTRIC ACTUATOR - A piezoelectric actuator is provided, including a piezoelectric layer which is joined to a joining member and which has a coefficient of linear expansion smaller than a coefficient of linear expansion of the joining member; a first electrode which is arranged on one surface of the piezoelectric layer; a second electrode which is arranged on a portion of the one surface of the piezoelectric layer different from the first electrode and which is in conduction with the first electrode; and a low dielectric layer which is formed between the piezoelectric layer and the second electrode and which has a dielectric constant lower than a dielectric constant of the piezoelectric layer. | 2013-04-04 |
| 20130084200 | APPARATUS FOR THE TREATMENT OF THE BLOOD - Apparatus for the treatment of the blood, comprising at least one pump ( | 2013-04-04 |
| 20130084201 | COMPRESSOR - A compressor valve structure permits improvement in durability and volumetric efficiency of a compressor and limits power losses. The width of the base portion of each suction reed valve is shorter than the width of the valve flap. The valve base plate has support portions, receiving portions, main coupling portions, and auxiliary coupling portions. Each support portion receives a central area of corresponding one of the valve flaps. The receiving portion receives a distal area of the valve flap. The main coupling portion extends from the support portion and couples the support portion to the receiving portion. The auxiliary coupling portion extends from the support portion. The suction ports are formed through the valve base plate, while leaving the support portions, the receiving portions, the main coupling portions, and the auxiliary coupling portions. | 2013-04-04 |
| 20130084202 | VANE ROTARY COMPRESSOR - In a vane rotary compressor, a discharge valve on a discharge flow channel communicates an operating chamber in a compression element with a discharge hole. The discharge valve is pushed from an opening portion of a discharge valve groove to an outer circumferential surface of a roller by a high-pressure refrigerant when pressure in an operating chamber is lower than the pressure of the high-pressure refrigerant. The discharge valve is pushed back into the discharge valve groove by the refrigerant pressure in the operating chamber when the pressure in the operating chamber is higher than the pressure of the high-pressure refrigerant. The discharge flow channel is closed by the outer circumferential surface of the discharge valve pushed out from the opening portion of the discharge valve groove and the outer circumferential surface of the roller, and opens when the discharge valve is pushed back into the discharge valve groove. | 2013-04-04 |
| 20130084203 | IRON-BASED SINTERED SLIDING MEMBER AND PRODUCTION METHOD THEREFOR - An iron-based sintered sliding member consists of, by mass %, 0.1 to 10% of Cu, 0.2 to 2.0% of C, 0.03 to 0.9% of Mn, 0.52 to 6.54% of S, and the balance of Fe and inevitable impurities. The iron-based sintered sliding member satisfies the following First Formula in which [S %] represents mass % of S and [Mn %] represents mass % of Mn in the overall composition. The iron-based sintered sliding member exhibits a metallic structure in which pores and sulfide particles are dispersed in the matrix that includes a martensite structure at not less than 50% by area ratio in cross section. The sulfide particles are dispersed at 3 to 30 vol. % with respect to the matrix. | 2013-04-04 |
| 20130084204 | METHOD OF MAKING ND-FE-B SINTERED MAGNETS WITH REDUCED DYSPROSIUM OR TERBIUM - A method of making a permanent magnet and a permanent magnet. The method includes providing combining a core material and a surface material so that the surface concentration of dysprosium, terbium, or both in the surface material is high while simultaneously keeping the bulk concentration of dysprosium, terbium, or both low. From this, the magnet has a non-uniform distribution of dysprosium, terbium or both. Varying approaches to preparing the combined core and surface materials may be used to ensure that the surface powder effectively wraps around the core powder as a way to achieve the high surface concentration and low bulk concentration. In one form, the core material may be made from a neodymium-iron-boron permanent magnet precursor material. | 2013-04-04 |
| 20130084205 | STEEL FOR STEEL TUBE WITH EXCELLENT SULFIDE STRESS CRACKING RESISTANCE - The present invention provides a steel which simultaneously satisfies a plurality of characteristics, specifically, a steel for tubes with excellent sulfide stress cracking resistance, including, C: 0.2 to 0.7%; Si: 0.01 to 0.8%; Mn: 0.1 to 1.5%; S: not more than 0.005%; P: not more than 0.03%; Al: 0.0005 to 0.1%; Ti: 0.005 to 0.05%; Ca: 0.0004 to 0.005%; N: not more than 0.007%; Cr: 0. 1 to 1.5%; and Mo: 0.2 to 1.0%; the balance being Fe, Mg and impurities, being characterized in that: the content of Mg is not less than 1.0 ppm and not more than 5.0 ppm; and inclusions of not less than 50% of the total number of those in steel have such a morphology that Mg—Al—O-based oxides exist at the central part of the inclusion, Ca—Al-based oxides enclose the Mg—Al—O-based oxides, and Ti-containing-carbonitrides further exist on a periphery of the Ca—Al-based oxides. | 2013-04-04 |
| 20130084206 | METHOD FOR PRODUCTION OF METALLIC TITANIUM AND METALLIC TITANIUM OBTAINED WITH THE METHOD - A method for production of metallic titanium and metallic titanium obtained with the method are provided. The method for production of metallic titanium comprises: taking a titaniferous material as the anode, a metal material as the cathode, and a molten salt material as the electrolyte, and carrying out electrolysis under electrolytic conditions to obtain metallic titanium; wherein, the titaniferous material is in a porous structure, with 1 mm˜10 mm average pore diameter and 20%˜60% porosity, and at least a part of the titanium element in the titaniferous material exists in the form of TiO | 2013-04-04 |
| 20130084207 | BRASS ALLOY - A brass alloy comprising (a) bismuth in an amount in the range from | 2013-04-04 |
| 20130084208 | ALUMINUM-BASED ALLOYS - In an aspect the disclosure relates to an alloy comprising, by weight, about 0.15% to about 1.00% zinc, 0% to about 0.20% gallium, and the balance aluminum and incidental elements and impurities, wherein the alloy has a corrosion potential from about −0.85 V to about −0.73 V relative to a saturated calomel electrode. | 2013-04-04 |
| 20130084209 | White Metal Babbitt for Rolling Mill Bushing - A tin based white metal alloy consisting essentially by weight of approximately 5.0%-0-9.0% antimony, approximately 3.0%-8.0% copper, approximately 0.1%-0.7% cobalt, and the balance tin. | 2013-04-04 |
| 20130084210 | SURFACTANTLESS METALLIC NANOSTRUCTURES AND METHOD FOR SYNTHESIZING SAME - Disclosed are nanowires and a nanowire synthesis method, with the nanowires synthesized by adding first and second solutions into a vessel containing a porous template, the first solution added on one side of the porous template and the second solution added on another side of the porous template. The first solution contains a metal reagent comprising at least one of a transition metal, an actinide and a lanthanide metal, and the second solution contains a reducing agent. | 2013-04-04 |
| 20130084211 | APPARATUS AND METHOD OF STERILIZING CONTAINERS WITH A CHARGE CARRIER SOURCE INTRODUCED INTO THE CONTAINERS - A method of sterilizing containers ( | 2013-04-04 |
| 20130084212 | SAMPLE PROCESSING APPARATUS - A sample processing apparatus includes: a sample processing unit comprising a moving mechanism and configured to perform a sample processing operation by moving the moving mechanism; a cover configured to cover the moving mechanism of the sample processing unit; a lock mechanism configured to lock the cover to prevent the cover from being opened; and a controller configured to control the lock mechanism, wherein the controller is configured to set either of a first mode and a second mode, wherein in the first mode, the cover is kept locked after the sample processing unit has completed the sample processing operation until an instruction to unlock the cover is received from a user, and in the second mode, the cover is automatically unlocked after the sample processing unit has completed the sample processing operation. | 2013-04-04 |
| 20130084213 | SAMPLE PROCESSING APPARATUS - A sample processing apparatus comprises a sample processing unit for processing a sample, a control unit for accepting a stop instruction to stop the operation of the sample processing unit, and an output unit. The control unit is configured to control the output unit to output consumable good information related to lack of the consumable good that occurs if the consumable good runs out before completion of next starting of the sample processing unit when accepting the stop instruction. | 2013-04-04 |
| 20130084214 | Ion-Selective Ion Concentration Meter - An ion concentration meter measures a concentration of an ion in a solution by exposing both an ISFET gate and a reference electrode within a filtered test area. In preferred embodiments, the test area filters preferred compounds from a solution being tested by occluding an opening to the test area with a species-selective membrane. Contemplated species-selective membranes include silicate membranes, chalcogenide membranes, lanthanum fluoride membranes, and valinomycin membranes. | 2013-04-04 |
| 20130084215 | HYDROGEN PEROXIDE GAS GENERATOR - A hydrogen-peroxide-gas generator includes: an atomizing unit to atomize hydrogen-peroxide solution stored in a storage portion by applying ultrasonic vibration; a heater provided above the atomizing unit, the heater configured to heat and gasify the hydrogen-peroxide solution atomized in the atomizing unit; an internal cylindrical portion, made of metal, whose internal space has the heater arranged therein, the internal cylindrical portion configured to guide upward the hydrogen-peroxide solution atomized in the atomizing unit flowing together with a carrier gas; and an external cylindrical portion, double-pipe constructed, whose internal space has the internal cylindrical portion arranged therein, having a gas-flow path for the carrier gas flowing downward toward the storage portion formed between the external cylindrical portion and the internal cylindrical portion, the carrier gas flowing through the gas-flow path caused to contact the internal cylindrical portion heated by the heater, the heated carrier gas introduced to the storage portion. | 2013-04-04 |
| 20130084216 | Heat Treating Furnace - The heat treating furnace for the gas reaction includes an outer body, an inner body, a heating mechanism, gas supplying mechanism, and a controller. Using the controller to control the amount of gas supply effectively keeps the first pressure (P | 2013-04-04 |
| 20130084217 | DIESEL PARTICULATE FILTER SYSTEM - A diesel particulate filter (“DPF”) system that is more convenient than a conventional DPF system, including a DPF having a catalyzed soot filter (“CSF”) that is connected to an exhaust pipe of a diesel engine in order to collect particulate matter (“PM”) in exhaust gas, and a diesel oxidation catalyst (“DOC”) provided on an upstream side of the CSF; and temperature sensors provided respectively on an upstream side and a downstream side of the DOC. When a PM accumulation amount in the CSF exceeds a fixed amount, DPF regeneration is performed by setting a temperature detected by the upstream side temperature sensor at or above a first threshold and setting a temperature detected by the downstream side temperature sensor at or above a second threshold. When a breakdown is detected in the upstream side temperature sensor, the second threshold is modified upward. | 2013-04-04 |
| 20130084218 | Anti-Bacterial Air System - This invention was designed to create cleaner air for healthier living. This is done with the installation of the Anti-bacterial Air System (ABAS) unit into homes or cars. This invention requires an existing A/C or car fan. The control panel of the ABAS will allow you to set the automatic timer and activate the ABAS. When the system is activated, it will mix the anti-bacterial agent and the scent, which will travel though the ¼″ PVC piping. Then the mixture will exit through the grill(s). The force and pressure of the A/C and car fan unit will facilitate the movement and spreading of the anti-bacterial and scent mist into car and room(s). Once airborne it will kill airborne bacteria and microbes and as it settles down on inanimate objects. The system will run 2-15 minutes depending on the size of home and car. | 2013-04-04 |
| 20130084219 | FCC REACTOR AND RISER DESIGN FOR SHORT CONTACT-TIME CATALYTIC CRACKING OF HYDROCARBONS - The present invention is an improved design and operation of a short contact time Fluid Catalytic Cracking (FCC) Reactor wherein the upper internal riser and a lower internal riser are in fluid connection with one another and provide an improved disengaging zone for entraining the vapors from the dilute phase area of the FCC reactor. Detailed preferred embodiments include improvements over the prior art to the internal central riser, riser termination apparatus, cyclone separators, and a coke mitigation baffle system, as well as associated improved fluid catalytic cracking processes utilizing the novel reactor design. | 2013-04-04 |
| 20130084220 | Ga-68 radionuclide generator structure - The invention is related a novel structure for Ga-68 radionuclide generator. It allows two washing solutions to pass through two Ge-68 absorbents to wash out different chemical forms of Ga-68 nuclide. The invention comprises the first method that will withdraw hydrochloric acid solution from the washing bottle and pass it through inorganic resin absorbing column to produce the radioisotope solution of Ga-68 gallium chloride, and the second method that will allow the radioisotope solution of Ga-68 gallium citrate to pass the organic resin absorbing column and then the silica-gel cartridge, and be washed by the hydrochloric acid solution to obtain the radioisotope solution of Ga-68 gallium chloride. | 2013-04-04 |
| 20130084221 | SYNTHESIS GAS METHOD AND APPARATUS - A method and apparatus for producing a synthesis gas product having one or more oxygen transport membrane elements thermally coupled to one or more catalytic reactors such that heat generated from the oxygen transport membrane element supplies endothermic heating requirements for steam methane reforming reactions occurring within the catalytic reactor through radiation and convention heat transfer. A hydrogen containing stream containing no more than 20 percent methane is combusted within the oxygen transport membrane element to produce the heat and a heated combustion product stream. The heated combustion product stream is combined with a reactant stream to form a combined stream that is subjected to the reforming within the catalytic reactor. The apparatus may include modules in which tubular membrane elements surround a central reactor tube. | 2013-04-04 |
| 20130084222 | Diesel Oxidation Catalyst with Layered Structure Containing Ceria Composition as Palladium Support Material for Enhanced HC and CO Gas Conversion - The present invention relates to a layered diesel oxidation catalyst (DOC) comprising: a) a carrier substrate; b) a diesel oxidation catalytic material comprising b1) a first layer located on the carrier substrate, the first layer comprising palladium impregnated on a support material comprising ceria in an amount of at least 45 weight-% based on the total weight of the support material, and optionally comprising platinum; b2) a second layer located on the first layer, the second layer comprising palladium and platinum each impregnated on a support material comprising a metal oxide; wherein the platinum to palladium weight ratio of the first layer is lower than the platinum to palladium weight ratio of the second layer. | 2013-04-04 |
| 20130084223 | THREE PHASE REACTOR - A reactor for carrying out a chemical reaction in a three phase slurry system providing a horizontal reaction vessel with a cross sectional area which is dependent on the vessel length, vessel diameter, and axial position. The vessel has a gas inlet at or near the bottom of the reaction vessel and a gas distributor. The gas product exits the vessel by conduit means at or near the top of the reaction vessel. The vessel includes a plurality of horizontal cooling coils to provide a cooling medium to the slurry. In the reaction vessel, the synthesis gas has an average linear velocity which is a function of the vessel cross sectional area. | 2013-04-04 |
| 20130084224 | MULTI-STREAM FEED INJECTOR - In certain embodiments, a feed injector system includes an inner channel configured to convey at least one of a solid fuel feed or a liquid reactant or moderator to a reaction zone. A first oxidizer channel extends around the inner channel, wherein the first oxidizer channel is configured to convey a first oxidizer stream to the reaction zone. A second oxidizer channel extends around the first oxidizer channel, wherein the second oxidizer channel is configured to convey a second oxidizer stream to the reaction zone. Additionally, a third channel extends around the inner channel and the first and second oxidizer channels, wherein the third channel is configured to convey at least one of the solid fuel feed or the liquid reactant or moderator to the reaction zone. | 2013-04-04 |
| 20130084225 | STEAM STERILIZER - A sterilizer for sterilizing instruments and devices disposed therein. The sterilizer includes a vessel that has an inner wall and an outer wall. The inner wall defines a sterilization chamber. The outer wall is spaced from the inner wall to define a cavity surrounding the sterilization chamber. A heating element for vaporizing a fluid is disposed in a lower portion of the cavity. A fluid circuit is fluidly connected to the vessel to convey fluid to the cavity, to convey steam from the cavity to the sterilization chamber and to exhaust steam from the sterilization chamber. The fluid circuit includes a conduit that fluidly connects the sterilization chamber to the cavity. A valve is disposed in the conduit for controlling the flow of steam from the cavity to the sterilization chamber. A boiler pump is provided for conveying fluid to the cavity of the vessel. | 2013-04-04 |
| 20130084226 | SENSING TEST BLOCK WITH RAPID CONDUCTIVE REACTION EFFECT - A sensing test block with rapid conductive reaction effect includes a test block body, reaction detector, reaction space and chemical reaction layer. A porous separation and filtering layer and a capillary guiding and diffusion portion are set onto the chemical reaction layer. The porous separation and filtering layer could separate the blood corpuscle in the test blood sample due to its smaller aperture, and the porous separation and filtering layer is provided with a guiding portion that is mated with the specimen inlet. The capillary guiding and diffusion portion is provided with a specimen guiding portion that is mated with the specimen inlet. A venting portion is set onto the capillary guiding and diffusion portion, and located correspondingly to the external side of the porous separation and filtering layer, making the venting portion farther from the specimen inlet than the porous separation and filtering layer. | 2013-04-04 |
| 20130084227 | HEAT BLOCK WITH INSULATING COLLAR - A heat block with an insulating collar for use in thawing frozen cells and viruses for vaccine production. | 2013-04-04 |
| 20130084228 | METHOD OF PREPARING POROUS CARBONATE APATITE FROM NATURAL BONE - A method for preparing carbonate apatite from natural bones. The method includes obtaining cancellous bone particles; treating the bone particles with hot water and an organic solvent; repeating the treating step at least once; drying the bone particles; and heating the bone particles at 500° C. to 620° C. for 10 to 50 hours. | 2013-04-04 |
| 20130084229 | METAL-CARBON COMPOSITIONS - A tin-carbon compound that is a reaction product of tin and carbon, wherein the tin and the carbon form a single phase material that is meltable. The compound is one in which the carbon does not phase separate from the tin when the single phase material is heated to a melting temperature. | 2013-04-04 |
| 20130084230 | METAL-CARBON COMPOSITIONS - A lead-carbon compound that is a reaction product of lead and carbon, wherein the lead and the carbon form a single phase material that is meltable. The compound is one in which the carbon does not phase separate from the lead when the single phase material is heated to a melting temperature. | 2013-04-04 |
| 20130084231 | METAL-CARBON COMPOSITIONS - A zinc-carbon compound that is a reaction product of zinc and carbon, wherein the zinc and the carbon form a single phase material that is meltable. The compound is one in which the carbon does not phase separate from the zinc when the single phase material is heated to a melting temperature. | 2013-04-04 |
| 20130084232 | METAL-CARBON COMPOSITIONS - A gold-carbon compound that is a reaction product of gold and carbon, wherein the gold and the carbon form a single phase material that is meltable. The compound is one in which the carbon does not phase separate from the gold when the single phase material is heated to a melting temperature. | 2013-04-04 |
| 20130084233 | PRODUCTION OF POLYCRYSTALLINE SILICON BY THE THERMAL DECOMPOSITION OF SILANE IN A FLUIDIZED BED REACTOR - Processes for producing polycrystalline silicon by thermal decomposition of silane are disclosed. The processes generally involve thermal decomposition of silane in a fluidized bed reactor operated at reaction conditions that result in a high rate of productivity relative to conventional production processes. | 2013-04-04 |
| 20130084234 | PRODUCTION OF POLYCRYSTALLINE SILICON BY THE THERMAL DECOMPOSITION OF SILANE IN A FLUIDIZED BED REACTOR - Processes for producing polycrystalline silicon by thermal decomposition of silane are disclosed. The processes generally involve thermal decomposition of silane in a fluidized bed reactor operated at reaction conditions that result in a high rate of productivity relative to conventional production processes. | 2013-04-04 |
| 20130084235 | CARBON NANOTUBE DEVICE, PROCESS FOR PRODUCTION OF CARBON NANOTUBE, AND DEVICE FOR PRODUCTION OF CARBON NANOTUBE - A new carbon nanotube device is provided. The carbon nanotube device has first carbon nanotubes and second carbon nanotubes that are different from each other in property. The carbon nanotube device includes: an object having a first carbon nanotube forming surface and a second carbon nanotube forming surface; first carbon nanotubes formed on the first carbon nanotube forming surface; and second carbon nanotubes formed on the second carbon nanotube forming surface, the second carbon nanotubes being different from the first carbon nanotubes in property. | 2013-04-04 |
| 20130084236 | PRODUCTION OF GRAPHENIC CARBON PARTICLES UTILIZING HYDROCARBON PRECURSOR MATERIALS - A method is disclosed for making graphenic carbon particles. The method includes introducing a hydrocarbon precursor material capable of forming a two-carbon-fragment species into a thermal zone, heating the hydrocarbon precursor material in the thermal zone to form the graphenic carbon particles from the hydrocarbon precursor material, and collecting the graphenic carbon particles. Apparatus for performing such a method, and graphenic particles produced by the method, are also disclosed. | 2013-04-04 |
| 20130084237 | PRODUCTION OF GRAPHENIC CARBON PARTICLES UTILIZING METHANE PRECURSOR MATERIAL - A method is disclosed for making graphenic carbon particles. The method includes introducing a methane precursor material into a thermal zone, heating the methane precursor material in the thermal zone to form the graphenic carbon particles from the methane precursor material, and collecting the graphenic carbon particles. Apparatus for performing such a method, and graphenic particles produced by the method, are also disclosed. | 2013-04-04 |
| 20130084238 | METHOD OF MAKING NANOMATERIAL AND METHOD OF FABRICATING SECONDARY BATTERY USING THE SAME - Disclosed are a method of making a nanomaterial and a method of fabricating a lithium secondary battery using the same. The method of making a nanomaterial includes preparing a mixed solution including a metal salt aqueous solution and an alkylamine, and hydrothermally treating the mixed solution. | 2013-04-04 |
| 20130084239 | METHOD OF PREPARING A TiO2 NANOSTRUCTURE - The present invention discloses a method preparing a TiO | 2013-04-04 |
| 20130084240 | PROCESS FOR MAKING SNO - Methods of preparing stannous oxide including neutralizing a solution of divalent tin ions in a mineral acid using a weak base, followed by heating the neutralized solution optionally under an inert atmosphere are provided. The stannous oxide particles produced are readily soluble in alkyl sulfonic acids. | 2013-04-04 |
| 20130084241 | DEVELOPMENT OF miRNA DIAGNOSTICS TOOLS IN BLADDER CANCER - The present invention includes methods and compositions related to diagnosis of bladder cancer, including the presence of bladder cancer and/or the type or stage of bladder cancer. In specific embodiments, the expression of one, two, three, four, five, or more miRNAs of the invention are associated with detection of bladder cancer, typing of bladder cancer, or staging of bladder cancer. Kits and microarrays are encompassed in the invention. | 2013-04-04 |
| 20130084243 | IGF-1R SPECIFIC ANTIBODIES USEFUL IN THE DETECTION AND DIAGNOSIS OF CELLULAR PROLIFERATIVE DISORDERS - The present invention relates to mammalian antibodies, designated 12B1 and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), preferably human IGF-IR. Also included are chimeric, bispecific, derivatized, single chain antibodies derived from the antibodies disclosed herein. Nucleic acid molecules encoding the mammalian antibodies as well as methods of use thereof are also disclosed. Also included are pharmaceutical compositions comprising these antibodies and methods of using the antibodies and compositions thereof for treatment and diagnosis of pathological hyperproliferative oncogenic disorders associated with expression of IGf-1R. | 2013-04-04 |
| 20130084244 | METHOD OF DIFFERENTIALLY DIAGNOSING DIFFERENT TYPES OF DEMENTIA - The present invention relates to a method of differentially diagnosing different types of dementia. In particular, the method relates to the use of specific SPECT tracers for differentially diagnosing Alzheimer's disease, Lewy-Body Dementia, and Frontotemporal Dementia. | 2013-04-04 |
| 20130084245 | PET MONITORING OF A-BETA-DIRECTED IMMUNOTHERAPY - The present invention provides methods of monitoring Aβ-directed immunotherapy. The methods involve administering a PET ligand that binds to amyloid deposits and detecting the PET ligand in the brain to provide an indication of the level and/or distribution of amyloid deposits. Surprisingly, the data in the present application show that a statistically significant reduction in amyloid deposits occurs early and consistently among patients following initiation of treatment before statistically significant effects of most if not all other markers are detectable. In consequence, the present methods allow early detection of whether a patient is responding to the Aβ-directed immunotherapy and if necessary adjustment of the immunotherapy regime. | 2013-04-04 |
| 20130084246 | METHOD AND SYSTEM FOR QUANTITATIVE RENAL ASSESSMENT - Method and system embodiments of the present invention employ computational analysis tools running on one or more computer systems to quantitatively analyze MRI data from patients in order to both assess various functional parameters and characteristics of a patient's kidney, as well as to provide an electronic display device interconnected with the one or more computer systems, and accessible visualization of the quantitative assessment to facilitate diagnosis of various types of kidney abnormalities and pathologies. | 2013-04-04 |
| 20130084247 | COMPOSITIONS AND METHODS TO PREVENT CANCER WITH CUPREDOXINS - The present invention discloses methods and materials for delivering a cargo compound into a cancer cell. Delivery of the cargo compound is accomplished by the use of protein transduction domains derived from cupredoxins. The cargo compound may be a nucleic acid and specifically a DNA, RNA or anti-sense. The invention further discloses methods for treating cancer and diagnosing cancer. | 2013-04-04 |
| 20130084248 | STABILIZED, BIOCOMPATIBLE GOLD NANOPARTICLES - The invention provides stabilized, biocompatible gold nanoparticles that are stabilized with material from polyphenols- or flavanoids-rich plant material or reactive phytochemical components of the plant material. The gold nanoparticles of the invention can be fabricated with an environmentally friendly method for making biocompatible stabilized gold nanoparticles. In preferred embodiments, the coating consists of material from polyphenols- or flavanoids-rich plant material or reactive phytochemical components of the plant material. | 2013-04-04 |
| 20130084249 | AUTHENTICATABLE COATINGS FOR PHARMACEUTICAL TABLETS AND INGESTIBLE MATERIALS - An authenticable and machine readable coating for pills, tablets and other ingestible materials is provided. The disclosure also relates to methods of authenticating the same. The coatings are formed from a lattice of particles stacked to cause selective diffraction such that each pill or tablet has an optical signature. The signature associated with each coating can be read and authenticated. In one embodiment, the particles are substantially spherical and self-organized. In one embodiment, generally recognized as safe (GRAS) materials are used to form the particles. | 2013-04-04 |
| 20130084250 | PREPARATION - The invention relates to a dye-containing preparation for use in ophthalmology and retinal surgery. | 2013-04-04 |
| 20130084251 | TREATMENT OF ACTIVE INFECTIONS AND RELATED COMPOSITIONS - The present invention is directed to the treatment of infections and the associated symptoms of sinusitis, rhinitis and related neurological disorders of the cranial cavity and facial tissue. More specifically, the present invention is directed to aerosols that are used to treat infections and the associated symptoms of sinusitis, rhinitis and related neurological disorders of the cranial cavity and facial tissue, compositions from which the aerosols are generated and methods of generating the aerosols. In an aerosol aspect of the present invention, an aerosol for delivery to the sinus cavity of a patient is provided. The aerosol includes at least: a) one or more compounds selected from antibiotics, antifungals, leukotriene antagonists, anti-TNF compounds, antihistamines, steroidal antiinflammatories, mucolytics, estrogen, progesterone and related hormones; and, b) water. The compounds are present in the water at a concentration ranging from 0.01 mg/kg to 1000 mg/kg, and the aerosol does not contain a surfactant. | 2013-04-04 |
| 20130084252 | Use of certain neoflavonoids for intensifying and/or producing a sensory impression of sweetness - The present invention primarily relates to the use of one or a plurality of neoflavonoids of formula (I) and/or one or a plurality of physiologically acceptable salts of one or a plurality of neoflavonoids of formula (I) for producing a sensory impression of sweetness (i.e. an impression of sweetness) in an orally consumable preparation or for intensifying the sensory impression of sweetness of an orally consumable preparation comprising at least one further sweet-tasting and/or sweet-smelling substance. The present invention further relates to certain semifinished products and certain orally consumable preparations containing one or a plurality of neoflavonoids of formula (I) and/or one or a plurality of physiologically acceptable salts of one or a plurality of neoflavonoids of formula (I). Finally the invention also relates to a method of producing an orally consumable preparation and a method of producing and/or intensifying a sensory impression of sweetness in/of an orally consumable preparation. | 2013-04-04 |
| 20130084253 | ORAL CARE COMPOSITIONS - The invention provides an oral care composition (preferably a dentifrice) comprising one or more curcumin compounds and a source of zinc ions. The incorporation of a source of zinc ions into the composition suppresses the degradation and/or discoloration of the curcumin compound(s) in the composition. | 2013-04-04 |
| 20130084254 | ORAL CARE COMPOSITIONS - The invention provides a non-aerated, foamable oral care composition comprising less than 1.5% anionic surfactant (by total weight anionic surfactant based on the total weight of the composition), abrasive cleaning agent and hydrophobin. The composition is mild to oral mucosa yet exhibits excellent foamability, texture and storage stability. | 2013-04-04 |
| 20130084255 | COSMETIC COMPOSITIONS COMPRISING LATEX FILM FORMERS - Disclosed are cosmetic compositions comprising at least one latex-film former chosen from at least one acrylate copolymer and derivatives thereof, and at least one coalescent and/or plasticizer. | 2013-04-04 |
| 20130084256 | COSMETIC COMPOSITIONS COMPRISING LATEX FILM FORMERS - Disclosed are cosmetic compositions comprising at least one latex-film former chosen from at least one random styrene acrylate copolymer and derivatives thereof, and at least one coalescent and/or plasticizer. | 2013-04-04 |
| 20130084257 | TRANSDERMAL ABSORPTION PROMOTER, AND EXTERNAL SKIN FORMULATION THEREOF - The present invention provides a substance which promotes the transdermal absorption of a pharmacologically active component while little irritating the skin. The present invention relates to a transdermal absorption promoter which comprises, as the active component, at least one member selected from among isopulegol, 2-(menthoxy)ethanol and 2-methyl-3-(menthoxy)propane-1,2-diol; and an external skin formulation which comprises a pharmacologically active component such as a psychotropic component, an anti-inflammatory component, an analgesic component, an antipyretic component, a whitening component or a hair growth-promoting component, together with the aforesaid transdermal absorption promoter. | 2013-04-04 |
| 20130084258 | METHOD FOR PREPARING BROUSSONETIA KAZINOKI EXTRACT - The present invention provides a method for preparing a | 2013-04-04 |
| 20130084259 | METHOD FOR PREPARING CUSTOMIZED COSMETICS - The present disclosure provides a method of manufacturing customized cosmetics in which a conventional cosmetics production process for producing complete products in a factory is segmented such that a base product, functional material and/or additive are produced or prepared in a factory individually, and a user may select the functional material and/or additive in accordance with usage preference and/or skin conditions of the user and mix the selected functional material and/or additives with the base product, thereby satisfying various needs of users and enabling each individual to prepare cosmetics tailored to him/her. | 2013-04-04 |
| 20130084260 | HAIR CARE COMPOSITION - A method of treating hair comprising the following steps: i) applying to the hair a composition comprising a group III or group IV metal salt or combination thereof; ii) followed by washing the hair. | 2013-04-04 |
| 20130084261 | POLY(BETA MALIC ACID) WITH PENDANT LEU-LEU-LEU TRIPEPTIDE FOR EFFECTIVE CYTOPLASMIC DRUG DELIVERY - The invention relates to the use of Polycefin-LLL nanoconjugate as a means of cytoplasmic delivery of drugs. In one embodiment, the present invention provides a drug delivery molecule, comprising a polymerized carboxylic acid molecular scaffold covalently linked to L-leucylleucylleucine. In another embodiment, the Polycefin-LLL includes drug antisense morpholino oligos, targeting antibodies, and a pH-sensitive endosome escape unit. In addition, the drug could be siRNA, microRNA, and aptamer. | 2013-04-04 |
| 20130084262 | REPAIRING BRUCH'S MEMBRANE WITH HYDROGELS - The invention provides hydrogels and methods for their use in treating disorders of the retina such as age-related macular degeneration (AMD). | 2013-04-04 |
| 20130084263 | Pharmaceutical kit and method for treating cancer - This invention is related to the field of cancer treatment, more specifically to gene therapy in combination with a suitable chemotherapeutic agent. The present invention is related to a new oncolytic virus, which is able to inhibit the growth of malignant tumors or is a treatment of hyperproliferative mammalian cells, or is a treatment of cancer. The oncolytic virus works in combination with a suitable chemotherapeutic agent. More specifically, the present invention provides a pharmaceutical kit comprising an oncolytic adenovirus and a chemotherapeutic agent, and a method for the treatment of cancer. | 2013-04-04 |
| 20130084264 | ANTI-TUMOR COMPOSITION - The present invention relates to pharmaceutical compositions comprising Avian Paramyxovirus (APMV) for use in the treatment of a tumor in a mammal. | 2013-04-04 |
| 20130084265 | DELIVERY SYSTEM FOR BIOLOGICAL COMPONENT - A controlled release delivery system composition and method applied to humans and animals, for oral, anal or vaginal administration of a biological component is disclosed. Preferably, a bacterium is delivered, and more preferably the bacterium is probiotic in nature, however, the biological component is not limited to the bacterium. | 2013-04-04 |
| 20130084266 | METHODS FOR GENERATING PANCREATIC TISSUE - This document provides methods and materials related to tissue generation. For example, methods for generating pancreatic tissue and providing a population of hormone-secreting cells, e.g., insulin-producing cells in a human subject are provided. | 2013-04-04 |
| 20130084267 | METHOD FOR STEM CELL DIFFERENTIATION - The present invention relates generally to a method for generating mesenchymal stem cells from pluripotent cells, the method comprising (i) differentiating a population of pluripotent stem cells in the presence of an inhibitor of endogenous activin and TGF-β signalling and (ii) passaging the cells differentiated in step (i) in the presence of a mesenchymal stem cell medium for a time and under conditions sufficient to produce mesenchymal stem cells. The present invention also relates to mesenchymal stem cells produced by the methods of the present invention and uses thereof. | 2013-04-04 |
| 20130084268 | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND/OR THE PREVENTION OF OSTEOARTICULAR DISEASES - An intra-articular pharmaceutical composition is used for the treatment and/or the prevention of acute or chronic osteoarticular diseases and acute or chronic osteoarticular symptoms especially osteoarthritis. The composition includes a possibly adequate pharmaceutical carrier or diluent, a glycosaminoglycan, a compound activating the alpha 2 adrenergic receptor, an anti-inflammatory agent and stem cells. | 2013-04-04 |
| 20130084269 | Methods and Compositions for Expanding and Stabilizing Natural Regulatory T Cells - The present invention is directed to methods and compositions for expanding and stabilizing the phenotype of natural regulatory T cells. In particular, the present invention provides methods and compositions for treating natural regulatory T cells that renders the cells resistant to factors present in the inflammatory milieu and stabilizes the suppressive properties of the cells. | 2013-04-04 |
| 20130084270 | STEM CELLS FROM ADIPOSE TISSUE, AND DIFFERENTIATED CELLS FROM SAID CELLS - The invention concerns adult multipotent human stem cells, characterized in that they have:
| 2013-04-04 |
| 20130084271 | Probiotic composition for pets and method of providing the same - A probiotic composition, delivery device, method of forming, and a method for delivery are disclosed. The composition may be in the form of a spray, mist, film, or the like suitable for use with any pre-formulated pet food product, whether in solid or liquid form, and further to the use of the spray directly on the coat or skin of an animal. The probiotic spray may also be applied directly into a cavity of the animal, for example into its mouth or nasal passages. The probiotic composition provides multiple strains or species of viable bacteria that provide health benefits when ingested, and is shown herein primarily for consumption by or use on/in animals, though the invention is not limited in any way to use strictly for animal intake, but may also be suitably used for human ingestion. | 2013-04-04 |
| 20130084272 | COMPOSITIONS, KITS AND METHODS FOR NUTRITIONAL SUPPLEMENTATION WITH TWELVE CARBON CHAIN FATTY ACIDS AND TWELVE CARBON CHAIN ACYLGLYCEROLS - The present invention relates to compositions, kits and methods for the administration of compositions and kits for supplementation with twelve carbon chain fatty acids or twelve carbon chain acylglycerols; and specifically for the supplementation with twelve carbon chain fatty acids such as lauric acid and twelve carbon chain acylglycerols such as monolaurin; and specifically for the co-supplementation with other vitamins, minerals and nutrients. | 2013-04-04 |
| 20130084273 | Variant Form of Urate Oxidase and Use Thereof - The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases. | 2013-04-04 |
| 20130084274 | Liquid, Aqueous Pharmaceutical Compositions of Factor VII Polypeptides - The present invention is directed to liquid, aqueous pharmaceutical compositions stabilised against chemical and/or physical degradation containing Factor VII polypeptides, and methods for preparing and using such compositions, as well as vials containing such compositions, and the use of such compositions in the treatment of a Factor VII-responsive syndrome. The main embodiment is represented by a liquid, aqueous pharmaceutical composition comprising at least 0.01 mg/mL of a Factor VII polypeptide (i); a buffering agent (ii) suitable for keeping pH in the range of from about 4.0 to about 9.0; and at least one stabilising agent (iii) comprising a —C(═N—Z | 2013-04-04 |
| 20130084275 | Methods and Compositions for Reducing Interleukin-4 or Interleukin-13 Signaling - The present invention relates generally to methods and compositions for reducing Interleukin-4 or Interleukin-13 signaling, in particular to treat asthma and atopic dermatitis. The inventors have found that Rac/PAK mediated endocytosis of the ligand bound type I (IL-4R with the chains IL-4Ra and IL-2-Rg) and/or type II receptor (IL-13R with the chains IL-4Ra and IL-13Ra1) is needed for the IL-4 and/or IL-13 mediated activation of downstream signalling events including phosphorylation of Stat family transcrition factors. These discoveries enable new methods of screening compounds that modulate Interleukin-4 and Interleukin-13 signalling, as well as new methods for treating conditions characterized by increased Interleukin-4 and Interleukin-13 levels. These conditions include inflammatory conditions, asthma bronchiale, atopic dermatitis, allergies, atopic syndromes, allergic rhinitis, and th2-induced conditions. | 2013-04-04 |
| 20130084276 | BIOMARKERS OF CARDIOVASCULAR DISEASE INCLUDING LRG - The invention relates to differentially expressed disease - associated proteins that have potential to identify patients with cardiovascular disease including ventricular dysfunction and heart failure and the potential to predict heart failure in patients. In particular, the invention relates to the use of a panel of biomarkers in the diagnostic and prognostic evaluation of cardiovascular patients. One of the markers is Leucine-rich alpha-2-glycoprotein (LRG). | 2013-04-04 |
| 20130084277 | FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE - The present invention provides pharmaceutical formulations for sustained release, and methods for delivering a treatment regimen with a combination of sustained release and long half-life formulations. The invention provides improved pharmacokinetics for peptide and small molecule drugs. | 2013-04-04 |
| 20130084278 | WATER SOLUBLE REACTIVE DERIVATIVES OF CARBOXY POLYSACCHARIDES AND FIBRINOGEN CONJUGATES THEREOF - The present invention provides water-soluble reactive esters of carboxy polysaccharides and derivatives thereof. The reactive carboxy polysaccharide derivatives are useful per se in aqueous solutions or specifically for the formation of water-soluble covalent fibrinogen conjugates. A preferred conjugate is a hyaluronic acid-fibrinogen conjugate and fibrin adhesive, clot or matrix derived from it. Methods of preparation and methods of use in tissue repair and regeneration are also disclosed. | 2013-04-04 |
| 20130084279 | COMPOSITIONS INCLUDING TRICIRIBINE AND TRASTUZUMAB AND METHODS OF USE THEREOF - This application relates to combination therapies including triciribine and related compounds and trastuzumab or a salt thereof and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation. | 2013-04-04 |
| 20130084280 | COMPOSITIONS INCLUDING TRICIRIBINE AND METHODS OF USE THEREOF - This invention encompasses combination therapies including TCN, TCN-P, TCN-PM and/or related compounds and one or more additional anti-cancer agents, for example, taxanes a molecule that modulates the HER2/neu (erbB2) receptor, anthracyclin compounds, epidermal growth factor receptor inhibitor compounds, one or more platinum compounds and bortezomib and derivatives thereof and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation. | 2013-04-04 |
| 20130084281 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER, TUMORS, AND TUMOR-RELATED DISORDERS - Described herein are compositions and methods for using these compositions in the treatment of cancer, tumors, and tumor-related disorders in a subject. | 2013-04-04 |
| 20130084282 | COMPOSITIONS AND METHODS FOR TARGETING TYPE 1 INTERFERON PRODUCING CELLS - The present disclosure provides a method for treating lupus, Sjörgen's syndrome or scleroderma, the method comprising administering to the mammal an immunoglobulin which binds an interleukin 3 receptor α (IL-3Rα) chain and which depletes or at least partly eliminates plasmacytoid dendritic cells (p DCs) and basophils to which it binds. | 2013-04-04 |
| 20130084283 | OLIGOMER-SPECIFIC AMYLOID BETA EPITOPE AND ANTIBODIES - A novel constrained peptide epitope derived from Aβ, wherein the eptitope comprises the amino acid sequence SNK, related antibody compositions and methods of use. An isolated antibody that specifically binds to a cyclic peptide comprising the conformational epitope which comprises the amino acid sequence SNK and corresponding to a solvent-exposed, antibody accessible knuckle region of oligomeric Aβ is described. An antigenic peptide comprising an epitope having a constrained cyclic configuration, which comprises the amino acid sequence SNK and corresponding to a solvent-exposed, antibody accessible knuckle region of oligomeric Aβ is also described. Methods of treating, preventing and diagnosing Alzheimer's disease are also described. | 2013-04-04 |
| 20130084284 | Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof - The present invention relates to antigen binding molecules (ABMs). In particular embodiments, the present invention relates to recombinant monoclonal antibodies, including chimeric, primatized or humanized antibodies specific for human EGFR. In addition, the present invention relates to nucleic acid molecules encoding such ABMs, and vectors and host cells comprising such nucleic acid molecules. The invention further relates to methods for producing the ABMs of the invention, and to methods of using these ABMs in treatment of disease. In addition, the present invention relates to ABMs with modified glycosylation having improved therapeutic properties, including antibodies with increased Fc receptor binding and increased effector function. | 2013-04-04 |
| 20130084285 | TREATMENT WITH ANTI-ALPHA2 INTEGRIN ANTIBODIES - The invention relates to a formulation of an anti-α2 integrin antibody for administration to a patient, which is suitable for the treatment of cancer. | 2013-04-04 |
| 20130084286 | DIAGNOSTIC MARKERS - The present invention provides methods of predicting response to a cancer therapy based on the methylation status of the ERBB2 gene. One aspect of the invention provides a method of predicting response to an EGFR inhibitor therapy based on the methylation status of the ERBB2 gene. | 2013-04-04 |
| 20130084287 | DIAGNOSTIC MARKERS - The present invention provides methods for determining epithelial and mesenchymal phenotype of tumors and predicting whether tumor growth will be sensitive or resistant to treatment with an EGFR inhibitor. | 2013-04-04 |
| 20130084288 | ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE PREVENTION AND TREATMENT OF NOTCH3-RELATED DISEASES - The present invention relates to antagonist antibodies that specifically bind to Notch 3 and inhibit its activation. The present invention includes antibodies binding to a conformational epitope comprising the first Lin12 domain and the second dimerization domain. The present invention also includes uses of these antibodies to treat or prevent Notch 3 related diseases or disorders. | 2013-04-04 |
| 20130084289 | TREATMENT OF MULTIPLE SCLEROSIS - The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20. | 2013-04-04 |
| 20130084290 | Antibodies to Thymic Stromal Lymphopoietin (TSLP) Receptor Molecules and Uses Thereof - The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides. | 2013-04-04 |
